BSE Live
Dec 08, 16:01Prev. Close
933.60
Open Price
933.60
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 08, 15:59Prev. Close
933.60
Open Price
934.70
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
897.75 (1182)
| Profit & Loss account of Natco Pharma (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| INCOME | ||||||
| Revenue From Operations [Gross] | 1,732.80 | 1,938.50 | 2,074.10 | 1,970.60 | 1,035.70 | |
| Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 17.20 | 44.80 | 37.80 | |
| Revenue From Operations [Net] | 1,732.80 | 1,938.50 | 2,056.90 | 1,925.80 | 997.90 | |
| Total Operating Revenues | 1,790.20 | 1,986.30 | 2,091.30 | 1,958.00 | 1,021.40 | |
| Other Income | 123.80 | 129.80 | 39.40 | 13.20 | 12.90 | |
| Total Revenue | 1,914.00 | 2,116.10 | 2,130.70 | 1,971.20 | 1,034.30 | |
| EXPENSES | ||||||
| Cost Of Materials Consumed | 329.00 | 333.10 | 390.50 | 520.80 | 303.70 | |
| Purchase Of Stock-In Trade | 123.90 | 31.50 | 22.70 | 68.70 | 0.40 | |
| Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -55.90 | -25.50 | -24.70 | -16.70 | -47.80 | |
| Employee Benefit Expenses | 356.10 | 340.20 | 312.20 | 232.10 | 171.90 | |
| Finance Costs | 20.60 | 18.80 | 14.70 | 17.50 | 21.90 | |
| Depreciation And Amortisation Expenses | 98.10 | 80.10 | 65.50 | 53.60 | 50.20 | |
| Other Expenses | 459.10 | 490.50 | 462.20 | 461.10 | 312.50 | |
| Total Expenses | 1,330.90 | 1,268.70 | 1,243.10 | 1,337.10 | 812.80 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 583.10 | 847.40 | 887.60 | 634.10 | 221.50 | |
| Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Profit/Loss Before Tax | 583.10 | 847.40 | 887.60 | 634.10 | 221.50 | |
| Tax Expenses-Continued Operations | ||||||
| Current Tax | 125.10 | 186.30 | 217.30 | 135.30 | 44.80 | |
| Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax | -20.50 | -6.00 | -27.90 | 0.00 | 0.20 | |
| Tax For Earlier Years | 4.00 | 0.00 | 0.00 | 4.00 | 0.00 | |
| Total Tax Expenses | 108.60 | 180.30 | 189.40 | 139.30 | 45.00 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 474.50 | 667.10 | 698.20 | 494.80 | 176.50 | |
| Profit/Loss From Continuing Operations | 474.50 | 667.10 | 698.20 | 494.80 | 176.50 | |
| Profit/Loss For The Period | 474.50 | 667.10 | 698.20 | 494.80 | 176.50 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| EARNINGS PER SHARE | ||||||
| Basic EPS (Rs.) | 26.08 | 36.22 | 39.38 | 28.27 | 10.17 | |
| Diluted EPS (Rs.) | 26.01 | 36.10 | 39.24 | 28.24 | 10.14 | |
| VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
| Equity Share Dividend | 127.40 | 91.90 | 150.90 | 117.60 | 21.80 | |
| Tax On Dividend | 26.20 | 18.90 | 30.80 | 24.00 | 4.40 | |
| Equity Dividend Rate (%) | 338.00 | 313.00 | 413.00 | 338.00 | 63.00 |
26.11.2025
Natco Pharma Consolidated September 2025 Net Sales at Rs 1,363.00 crore, down 0.59% Y-o-Y
24.11.2025
Natco Pharma Standalone September 2025 Net Sales at Rs 1,264.30 crore, down 2.19% Y-o-Y
24.11.2025
24.11.2025
26.11.2025
Natco Pharma Consolidated September 2025 Net Sales at Rs 1,363.00 crore, down 0.59% Y-o-Y
24.11.2025
Natco Pharma Standalone September 2025 Net Sales at Rs 1,264.30 crore, down 2.19% Y-o-Y
14.11.2025
Natco Pharma Consolidated September 2025 Net Sales at Rs 1,363.00 crore, down 0.59% Y-o-Y
09.09.2025
Natco Pharma Standalone June 2025 Net Sales at Rs 1,192.70 crore, down 3.57% Y-o-Y